Artikel om ISR publicerad på VA Finans
Artikel “Vi kan ha ett potentiellt botemedel för HIV” publicerades på VA Finance idag För att läsa hela artikeln klicka här
Signing with CRDGC
ISR CEO Mikael Brönnegård signing a MoU with Chairman of CRDGC Li Juan Jun in a meeting in Beijing April 7, 2017. For more information regarding CRDGC please click here.
Kallese till Årstämma
ISR IMMUNE SYSTEM REGULATION HOLDING AB Aktieägarna i ISR Immune System Regulation Holding AB (publ) kallas härmed till årsstämma torsdagen den 9 februari 2017, kl. 14.00 på Advokatfirman [...]
Broad-spectrum antiviral drugs
Recent pandemic threats caused by new and old virus infections have emphasized the urgent need to develop drugs that not only target the life cycle of the virus but also boost the immune system...
Progress in drug development against HIV
According to www.clinicaltrials.gov there are more than 7 000 clinical trials that investigate various aspects of HIV infected patients including investigational research...
Cancer immunotherapy
The immune system has been in focus to treat cancer for many years. Using the immune system to treat cancer cover a vast range of different research areas...
Global HIV vision
To provide solutions for treatment and cure of HIV and other viral infections in all countries on earth.
